N-Methyl-N-((3R,4R)-4-methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine hydrochloride, 95.0%, 10g

Thymidine-5'-monophosphate (disodium) salt, 100mg

2-(Chloromethyl)-3,5-dimethyl-4-pyridinyl methyl ether hydrochloride, 95.0%, 1kg

3-Methyl-3-oxetanemethanol>96.0%(GC)5g

tert-butyl 3-(propan-2-yl)-2H,4H,5H,6H,7H-pyrazolo[4,3-c]pyridine-5-carboxylate, 95%, 1g

2-(4,6-Dichloropyrimidin-5-yl)ethanol, 95.0%, 10g

4-Chloro-2-methylquinoline, 97.0%, 25g

(2,3,5,6-Tetrafluoro-4-(methoxymethyl)phenyl)methanol, 95.0%, 100g

4-(Pyridin-3-yloxy)benzoic acid, 95.0%, 1g

5-Bromo-2-(pyrrolidin-3-yloxy)pyrimidine, 95.0%, 100mg

(R)-5-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-2-((tert-butoxycarbonyl)amino)pentanoic acid, 95%, 250mg

4-((Benzyloxy)carbonyl)benzoic acid, 98%, 5g

4-aminobenzoic acid, min. 98.5%, for synthesis, 50 g, plastic packaging.